Abnormal basal results are shown in Fig 1. Serum luteinizing hormone (LH) levels (Marshall et al. 1972 ) were persistently at the upper limit of or above the normal adult male range, as were the plasma 17fl-hydroxy androgens (17-OHA) (Ander-son 1970) . Plasma testosterone high, 15 ng/ml (Dr W Collins). Plasma sex-hormone-binding globulin (SHBG), measured by reversed saturation analysis (Anderson, Peppiatt et al. 1972) , was persistently elevated, and percentage of unbound testosterone, measured by steady-state gel filtration (Burke 1969 , Marshall et al. 1972 ), was persistently low. Unbound 17-OHA (total 17-OHA x percentage of unbound testosterone) normal. Plasma cestradiol (Corker & Exley 1970) normal or high. Bilateral testicular biopsy showed diminished spermatogenesis and moderate Leydig cell hyperplasia. Dynamic function tests: On fluoxymesterone 80 mg/day for two days, LH fell from 4.8 to 2.3 mu/ ml. After human chorionic gonadotrophin (HCG) 2000 iu i.m., 17-OHA rose from 23 to 51 ng/ml (supranormal response, Anderson, Marshall et al. 1972) , and cestradiol rose from 2.0 to 9.6 ng/ 100 ml. On clomiphene 200 mg daily for ten days, LH rose from 4.2 to 12.1 mu/ml, 17-OHA from 33 to 62 ng/ml (supranormal). and cestradiol from 3.4 to 43.6 ng/100 ml (confirmed by radioimmunoassay).
Discussion
There seems little doubt that this patient's gynecomastia and impotence are linked to the abnormalities described above. The dynamic function tests demonstrate clearly that the hypothalamus-pituitary-testicular axis is intact although functioning abnormally. Injections of Primoteston Depot 250 mg i.m. twice monthly for three months produced no change in symptoms. However, this dosage was inadequate to produce a sustained rise in total or free 17-OHA, 12 or a fall in LH; SHBG levels also remained elevated.
We suggest that since the plasma aestradiol level was only moderately raised it is unlikely that increased (estrogen production has stimulated the increased hepatic SHBG production; indeed, this rise in astradiol may be a consequence of the elevated SHBG, since aestradiol as well as testosterone binds to this protein. Thyrotoxicosis is associated with elevated SHBG accompanied by high total and bound testosterone and increased plasma LH levels (Crepy et al. 1967 , Ruder et al. 1971 ; this cause has been excluded in our patient. We suggest, however, that an increase in hepatic SHBG production following an attack ofjaundice may be the primary endocrine abnormality in our patient. Increased SHBG production would result in a fall in free testosterone and this would stimulate increased LH production with consequent Leydig cell stimulation. This would cause increased androgen production until the free testosterone level (monitored by the hypothalamus) returned to normal.
The suggested sequence of events in this patient parallels that seen in experimental hyperthyroidism induced in normal men by triiodothyronine administration, where a progressive rise in SHBG was accompanied by a marked elevation in bound testosterone and an increase in serum LH levels (Ruder et al. 1971 ). The following cases were also presented: Large doses of ACTH given over a period of time will suppress the release of further endogenous ACTH in conditions of stress (Plager & Cushman 1962) . This effect is thought to occur in the brain and not in the pituitary gland and to be a direct action of ACTH rather than a result of the feedback action of the corticoids released from the adrenal glands (Penn & Sadow 1972) .
In our experiments, groups of male Wistar rats were given tetracosactrin (Cortrosyn) subcutaneously at 12 noon each day for 20 days. One group was given 0.05 pgg/100 g body weight per day and another group 0.5 pg/100 g body weight per day. Control animals were given an equivalent volume of saline subcutaneously each day for the same period.
The smaller dose caused a daily elevation of plasma corticosterone which was similar to that produced by a mild stress, the larger dose being comparable to a severe stress. The functional activity of the hypothalamo-pituitary-adrenal (HPA) system was assessed in both groups of test and control animals 24 h after the last treatment by submitting the animals to a standard ether stress. 
